Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 1434 | 12q24.22 | NOS1 | nitric oxide synthase 1 | |
Mouse | - | 1429 | 5 57.29 cM | Nos1 | nitric oxide synthase 1, neuronal | |
Rat | - | 1429 | 12q16 | Nos1 | nitric oxide synthase 1 |
Database Links | |
Alphafold | P29475 (Hs), Q9Z0J4 (Mm), P29476 (Rn) |
BRENDA | 1.14.13.39 |
CATH/Gene3D | 3.40.50.360 |
ChEMBL Target | CHEMBL3568 (Hs), CHEMBL4719 (Mm), CHEMBL3048 (Rn) |
Ensembl Gene | ENSG00000089250 (Hs), ENSMUSG00000029361 (Mm), ENSRNOG00000001130 (Rn) |
Entrez Gene | 4842 (Hs), 18125 (Mm), 24598 (Rn) |
Human Protein Atlas | ENSG00000089250 (Hs) |
KEGG Enzyme | 1.14.13.39 |
KEGG Gene | hsa:4842 (Hs), mmu:18125 (Mm), rno:24598 (Rn) |
OMIM | 163731 (Hs) |
Pharos | P29475 (Hs) |
SynPHARM |
83559 (in complex with compound 14j [PMID: 27050842]) 83560 (in complex with compound 14j [PMID: 27050842]) 78396 (in complex with Nωpropyl-L-arginine) |
UniProtKB | P29475 (Hs), Q9Z0J4 (Mm), P29476 (Rn) |
Wikipedia | NOS1 (Hs) |
Selected 3D Structures | |||||||||||||
|
Enzyme Reaction | ||||
|
Products | ||||||||||||
|
Cofactors | ||||||||||||||||||||||||||||||||
|
Endogenous Substrate (Human) |
L-arginine |
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View species-specific inhibitor tables |
Other Binding Ligands | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
1. Collins JL, Shearer BG, Oplinger JA, Lee S, Garvey EP, Salter M, Duffy C, Burnette TC, Furfine ES. (1998) N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity. J Med Chem, 41 (15): 2858-71. [PMID:9667974]
2. Connolly S, Aberg A, Arvai A, Beaton HG, Cheshire DR, Cook AR, Cooper S, Cox D, Hamley P, Mallinder P et al.. (2004) 2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution. J Med Chem, 47 (12): 3320-3. [PMID:15163211]
3. Shearer BG, Lee S, Franzmann KW, White HA, Sanders DC, Kiff RJ, Garvey EP, Furfine ES. (1997) Conformationally restricted arginine analogues as inhibitors of human nitric oxide synthase. Bioorganic and Medicinal Chemistry Letters, 7: 1763-1768. DOI: 10.1016/S0960-894X(97)00309-0
4. Sun N, Qin YJ, Xu C, Xia T, Du ZW, Zheng LP, Li AA, Meng F, Zhang Y, Zhang J et al.. (2022) Design of fast-onset antidepressant by dissociating SERT from nNOS in the DRN. Science, 378 (6618): 390-398. [PMID:36302033]
5. Wang HY, Qin Y, Li H, Roman LJ, Martásek P, Poulos TL, Silverman RB. (2016) Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker. J Med Chem, 59 (10): 4913-25. [PMID:27050842]
6. Zhang HQ, Fast W, Marletta MA, Martasek P, Silverman RB. (1997) Potent and selective inhibition of neuronal nitric oxide synthase by N omega-propyl-L-arginine. J Med Chem, 40 (24): 3869-70. [PMID:9397167]